Cargando…

Dexamethasone for treatment of severe COVID-19, a surprise?

Detalles Bibliográficos
Autor principal:	Elsayed, Hany Hasan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512210/ http://dx.doi.org/10.1186/s43057-020-00032-1

Ejemplares similares

COVID-19 and Kawasaki syndrome: should we really be surprised?
por: Loomba, Rohit S., et al.
Publicado: (2020)

A tentative guide for thoracic surgeons during COVID-19 pandemic
por: Ghoniem, Ahmed, et al.
Publicado: (2020)

Plasmacytoma of the trachea: a surprising diagnosis
por: Duarte, Márcio Luís, et al.
Publicado: (2017)

Monkeypox in the elderly: Is an unwelcome surprise to be expected?
por: Bruno, Giuseppe, et al.
Publicado: (2022)

Dexamethasone Treatment for COVID-19-Related Lung Injury in an Adult with WHIM Syndrome
por: Akahane, Daigo, et al.
Publicado: (2021)

Severe COVID-19 along with Cytokine Storm in Pemphigus Vulgaris Managed Successfully with Dexamethasone Pulse Therapy
por: Pradhan, Swetalina, et al.
Publicado: (2021)

Worrying situation regarding the use of dexamethasone for COVID-19
por: Lim, Michael Anthonius, et al.
Publicado: (2020)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Dexamethasone and COVID-19 in a Developing Country: Appropriate Use?
por: Marreros, Diego Martin Moreno, et al.
Publicado: (2021)

Harm of early dexamethasone for COVID-19 and bias in randomized trials
por: Núñez, Isaac, et al.
Publicado: (2023)

A surprising intravitreal injection attempt: Ozurdex™ implantation for Behçet's disease
por: Furundaoturan, Onur, et al.
Publicado: (2020)

Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
por: Liu, Dongsheng, et al.
Publicado: (2023)

A surprising cause of isolated oculomotor nerve palsy with pupillomotor palsy
por: Mahale, Rohan R., et al.
Publicado: (2016)

Both kinds of RNase P in all domains of life: surprises galore
por: Daniels, Charles J., et al.
Publicado: (2019)

Basal Cell Carcinoma Arising from an Epidermoid Cyst: A Histopathological Surprise
por: Khullar, Geeti, et al.
Publicado: (2020)

Does Vitamin D have a role to play in Covid-19 in the dexamethasone era?
por: Mandal, Amit KJ., et al.
Publicado: (2021)

Presentation of mucinous adenocarcinoma of renal pelvis masquerading as gross hydronephrosis: A histopathological surprise
por: Patel, Kajal Nitin, et al.
Publicado: (2017)

Giant Meckel's Diverticulum with “Daughter”/“Grand-daughter” Diverticula: An “On-Table” Surprise at an Acute Abdomen
por: Jategaonkar, PA, et al.
Publicado: (2014)

Periodic troubleshooting of LENSTAR® encoder disc's motor for preventing surprise dust induced crashes
por: Ramesh, Prasanna V, et al.
Publicado: (2021)

Treatment algorithm with dexamethasone intravitreal implant in patients with diabetic macular edema
por: Epstein, David, et al.
Publicado: (2019)

Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?
por: Hasan, Md. Jahidul, et al.
Publicado: (2021)

Impact of COVID-19 on Urologists: Learning on the Go
por: Desouky, Elsayed
Publicado: (2020)

Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'
por: Ellsworth, Susannah, et al.
Publicado: (2015)

Commentary on “Intravitreal dexamethasone implant for management of treatment-naïve retinal vein occlusion”
por: Bansal, Mayank
Publicado: (2018)

Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
por: Mateos, Maria V., et al.
Publicado: (2021)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Effects of dexamethasone on immune dysfunction and ventilator-associated pneumonia in COVID-19 acute respiratory distress syndrome: an observational study
por: Cour, Martin, et al.
Publicado: (2021)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Dexamethasone in severe COVID-19 infection: A case series
por: Hassan, Mohamed Eliwa, et al.
Publicado: (2020)

A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
por: Joumaa, H., et al.
Publicado: (2020)

Intravenous Lipid Emulsion for treating Tramadol-Induced Seizures: Surprising but Worth Considering for Future Studies; a Letter to Editor
por: Mégarbane, Bruno, et al.
Publicado: (2022)

Perineal pruritus in epidural dexamethasone injections
por: Veilleux, Catherine, et al.
Publicado: (2019)

A case of scleromyxedema responding to lenalidomide and dexamethasone
por: Rambhia, Sweta, et al.
Publicado: (2017)

Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen
por: Jacobus, S J, et al.
Publicado: (2016)

Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Response to: Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'
por: Wong, Eric T, et al.
Publicado: (2015)

Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone
por: Wang, Di, et al.
Publicado: (2021)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

Severe and treatment-resistant hypocalcemia in patient with bilateral COVID-19 pneumonia()
por: Pla, Begoña, et al.
Publicado: (2021)

Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
por: Huo, Shufan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qrdaj9cuka97j6hv6robao0ipj